Accueil 5 About us

ABOUT US

MOOVENCY, created in November 2018, is a start-up specialized in quantifying the risks of musculoskeletal disorders in industrial environments. Based in Rennes, we operate throughout France.

OUR VISION

From our background in the field of sports science, we believe that your worker are everyday high level athletes ! Because they have to perform at their best in their work, while protecting their bodies from injuries and traumas caused by their everyday activities. It is therefore necessary to support them in the management of their effort in order to preserve their health in the long term.

For Moovency, prevention is a performance factor whatever your field of activity, your needs or type of organization. This is why we strive every day to provide you with reliable, scientifically proven measurements, while maintaining a simplicity of use that we believe is essential for optimal efficiency.

We are deeply attached to the culture of the field and operations. Our mission is to support you in your overall prevention policy, by providing you with a complete platform that meets all your MSD risk prevention needs.

call our team

Contact us

THE ORIGIN OF MOOVENCY

Moovency was created following a collaboration between Faurecia, the M2S laboratory (Research in movement, sport and health) of the Rennes 2 University and Pierre Plantard, in a research project. The M2S laboratory has been oriented towards ergonomics for 10 years now, thanks to its expertise in the analysis and measurement of human movement. The partnership with Faurecia was built around a strong laboratory topic: the development of an innovative and ambulatory movement measurement system.

This partnership began in 2012 with a research internship at Faurecia to validate the project’s feasibility. Following this, a thesis was initiated between the M2S laboratory of the Rennes 2 University and Faurecia on the development of a tool to help assess the risk of musculoskeletal disorders on workers performing shift work. This thesis, supported in 2016, led to the development of the KIMEA software.

The results obtained and the application perspectives of those research have enabled the different stakeholders to go further in the development of the solution. The need was the transition from a functional prototype to an industrialized product with a commercialization objective. This objective was supported by SATT Ouest valuation, which resulted in the implementation of a 15-month maturation program. At the end of the maturation program (November 2018), Moovency was created in order to start selling the first version of KIMEA.

Discover KIMEA